About Cardiovascular Systems
Cardiovascular Systems is a company based in Saint Paul (United States) founded in 1989 was acquired by Abbott in February 2023. Cardiovascular Systems has raised $121.34 million across 10 funding rounds from investors including Abbott, Maverick Ventures and Easton Capital Investment Group. The company has 780 employees. Cardiovascular Systems offers products and services including Diamondback 360, ViperWire Advance, and Stealth 360. Cardiovascular Systems operates in a competitive market with competitors including Contego Medical, AngioScore, Echopoint Medical, Shape Memory Medical and Limflow, among others.
- Headquarter Saint Paul, United States
- Employees 780
- Stage Public
- SectorsHealthcare
- Website csi360.com
- Social LinkedIn
- Acquired by Abbott (Feb 2023)
Products & Services of Cardiovascular Systems
Cardiovascular Systems offers a comprehensive portfolio of products and services, including Diamondback 360, ViperWire Advance, and Stealth 360.
System for treating calcified arterial lesions in patients.
Guide wire used in atherectomy and vascular procedures.
Device for orbital atherectomy in peripheral vessels.
Funding Insights of Cardiovascular Systems
Cardiovascular Systems has successfully raised a total of $121.34M across 10 strategic funding rounds. The most recent funding activity was a Post-IPO round of $13.5 million completed in March 2013. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $121.34M
- Total Rounds 10
- Last Round Post-IPO — $13.5M
- First Round $140,000
(Aug 2002)
- Investors Count 3
All 10 funding rounds of Cardiovascular Systems with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar 2013 | $13.5M | Post-IPO | – | – | – |
| May 2011 | $40,116 | Post-IPO | – | – | – |
| Dec 2010 | $3.5M | Post-IPO | – | – | – |
| Jan 2008 | $11.22M | Post-IPO | – | – | |
| Jul 2006 | $25M | Post-IPO | – | – | |
| Sep 2005 | $62.5M | Series B | – | – | – |
| Nov 2004 | $46M | Series A | – | – | – |
| May 2004 | $7.7M | Series A | – | – | – |
| Jun 2003 | $5M | Series A | – | – | – |
| Aug 2002 | $140,000 | Unspecified | – | – | – |
4 investors in total: 4 institutional.
Investors in Cardiovascular Systems
Cardiovascular Systems has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include Abbott, Maverick Ventures and Easton Capital Investment Group.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Early-stage tech and life-sciences firms are funded across the US. | – | maverickventures.com | San Francisco, United States | |
- | – | eastoncapital.com | - | |
Corporate-backed venture capital firm focused on healthcare, IT, and multiple sectors | – | mitsui-global.com | Menlo Park, United States | |
Developer of medical devices, generic pharmaceuticals, and nutrition products | 1888 | abbott.com | Libertyville, United States |
Investor details for Cardiovascular Systems
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Cardiovascular Systems
63 people are tracked at Cardiovascular Systems (17 in leadership, 3 in board & advisors, 43 in team); the tracked headcount is 780.
| Name | Role | Group |
|---|---|---|
Jeffrey S. Points | CFO | Leadership |
Andrew P. O’Brien | VP, Information Technology | Leadership |
Peter F. Hirshman | VP, Quality & Operations | Leadership |
Philip B. Freed | VP, Marketing | Leadership |
Brian Catalano | Vice President, National Accounts | Leadership |
Barbara Kind | Sr. Director, Health Economics & Research | Leadership |
Tony Winters | Director, Global Medical Affairs, Cardiovascular Training | Leadership |
Emerson Marques | Vice President - Marketing, Portfolio Strategy And Commercial Operations | Leadership |
Christopher Ryan | Director Of International Markets (business Development & Sales) At Cardiovascular Systems, Inc. | Leadership |
Jim Wilson | Sr. Director, Digital Marketing Transformation And Customer Communications | Leadership |
Peter Jaccarino | Director National Accounts | Leadership |
Ron Ward | Director Of National Accounts | Leadership |
Jeffery W. Chambers | Chief Medical Officer | Leadership |
Scott R. Ward | President & CEO | Leadership |
John E. Nielsen | VP, Investor Relations & Corporate Communications | Leadership |
Sandra M. Sedo | Chief Compliance Officer | Leadership |
Todd Vanacore | Regional Sales Director | Leadership |
Kelvin Womack | Director | Board & advisors |
Stephen Stenbeck | Director | Board & advisors |
Augustine Lawlor | Director | Board & advisors |
43 more people are available in the full profile.
Complete people profiles for Cardiovascular Systems
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Cardiovascular Systems
5 dated milestones of Cardiovascular Systems across 34 years, from founding to its latest funding, stage changes and deals.
- Founded Cardiovascular Systems is founded.
- Funding First funding round of $140K.
- IPO Lists on the stock exchange (IPO).
- Funding Latest funding round, Post-IPO, of $13.5M.
- Exit Acquired by Abbott.
Competitors of Cardiovascular Systems
Cardiovascular Systems operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Contego Medical, AngioScore, Echopoint Medical, Shape Memory Medical and Limflow, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| contegomedical.com | 2005 | Raleigh, United States | $66.01M | – | Provider of vascular stenting with embolic protection for both coronary and peripheral vasculature | |
| angioscore.com | 2003 | Fremont, United States | $87M | – | Scoring balloon catheters for coronary and peripheral angioplasty are developed. | |
| echopointmedical.com | 2018 | London, United Kingdom | $9.74M | 8 | Smart devices for monitoring coronary artery disease are developed. | |
| shapemem.com | 2009 | Santa Clara, United States | $77.27M | 37 | Embolization devices are developed using Shape Memory Polymer foams. | |
| limflow.com | 2012 | Paris, France | $97.45M | – | Developer a system for venous arterialization of the lower limbs | |
| terumo.com | 1921 | Somerset, United States | – | – | Portfolio of medical devices for interventional cardiology is provided. | |
| vasc.com | 1997 | Minneapolis, United States | $12M | 562 | Products for vascular diagnostics and interventional procedures are developed. | |
| ev3.net | 2000 | Plymouth, United States | $58.8M | 1,307 | Surgical products for treatment of Peripheral vascular & Neurovascular diseases | |
| vascular-flow.com | 1998 | Dundee, United Kingdom | $16.79M | 10 | Vascular devices are developed using spiral laminar flow technology. |
Detailed competitors of Cardiovascular Systems
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Cardiovascular Systems
The website of Cardiovascular Systems (csi360.com) receives about 2.6K visits a month.
- Monthly visits2.6K
▲ 30.1% vs previous month
Websites whose visitors overlap most with Cardiovascular Systems. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| medrad.com | 100% | – | – | View details | |
| texasheart.org | 99% | 590.5K | #114,882 | View details | |
| bardpv.com | 99% | 1.4K | #13,184,975 | View details | |
| merillife.com | 99% | 81.5K | #441,984 | View details | |
| bostonscientific.com | 99% | 738.5K | #88,615 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 8 similar websites and full traffic analytics for Cardiovascular Systems
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 8 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Latest news on Cardiovascular Systems
Complete news archive for Cardiovascular Systems
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Cardiovascular Systems
10 companies that operate in the same segment as Cardiovascular Systems (Cardiac and Vascular Disorders), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Connected devices for health, sleep, and activity monitoring are developed. | 2008 | Moulineaux, Seine-maritime, France | USD 93.83 M | – | – | |
SMT is recognized as a developer of cardiovascular medical devices. | 1998 | Surat, Gujarat, India | USD 57.22 M | USD 106.25 M | 1,090 | |
Gene-editing therapies for coronary artery disease are developed. | 2018 | Cambridge, Massachusetts, United States | USD 215.5 M | – | 255 | |
Cardiac monitoring devices and applications are provided for heart health. | 2010 | Mountain View, California, United States | USD 114.38 M | USD 6.18 M | 67 | |
Therapies for lowering low-density lipoprotein cholesterol levels are developed. | 1998 | Ann Arbor, Michigan, United States | USD 129.7 M | USD 332.31 M | 304 | |
Cloud-based ambulatory ECG monitors for cardiac arrhythmia diagnosis are provided. | 2006 | San Francisco, California, United States | USD 109.23 M | USD 747.14 M | 2,000 | |
Provider of neuroprotection devices for carotid artery disease | 2007 | Sunnyvale, California, United States | USD 241.8 M | – | – | |
Miniaturized wireless implantable sensors are developed for hemodynamic monitoring. | 2007 | East Peoria, Illinois, United States | USD 154.77 M | – | 104 | |
Access catheters for neurovascular stroke treatment are provided. | 2015 | Campbell, California, United States | USD 596 M | – | – | |
Biosensor patches are developed for monitoring multiple body vitals. | 2011 | Campbell, California, United States | USD 239.95 M | – | 184 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Cardiovascular Systems
Cardiovascular Systems was founded in 1989 and raised its 1st funding round 13 years after it was founded.
Cardiovascular Systems is headquartered in Saint Paul, United States. It is registered at Saint Paul, Minnesota, United States.
Cardiovascular Systems is a funded company, having raised a total of $121.34M across 10 funding rounds to date. The company's 1st funding round was a Unspecified of $140K, raised on Aug 2002.
Cardiovascular Systems has 780 employees.
Cardiovascular Systems was founded in 1989 and is headquartered in Saint Paul, United States. Medical devices for addressing peripheral and coronary vascular disease are developed and provided by the company within the healthcare sector. Operations focus on innovative tools, including the Orbital Atherectomy Systems, which are designed to treat calcified and fibrotic plaque in arterial vessels of the legs and heart.
Cardiovascular Systems's top competitors include Contego Medical, Limflow and Shape Memory Medical.
Cardiovascular Systems offers Diamondback 360, ViperWire Advance, and Stealth 360.
Cardiovascular Systems has 4 investors. Key investors include Abbott, Maverick Ventures, Easton Capital Investment Group, and Mitsui Global Investment.
Yes. Cardiovascular Systems was acquired by Abbott in February 2023.